Vantage Specialties, Inc. has named Stephen Doktycz as its CEO, a position he has been serving in the interim status since October 2019. He will also sit on the company’s board of directors and is an equity investor alongside H.I.G. Capital, LLC in the company.
Previously: Vantage Unveils ‘Clear’ Solutions for Skin
Before joining Vantage, Doktycz spent more than 27 years with The Dow Chemical Company in several leadership positions, including corporate director and global director of corporate and strategic development.
Most recently, he served as a senior advisor the H.I.G. from LyondellBasell, a plastics, chemical and refining company where he held the position of senior vice president, strategic planning and transactions. His responsibilities at LyondellBasell included defining corporate vision and strategy and driving inorganic growth.
Doktycz has a Ph.D. in chemistry from the University of Illinois at Urbana-Champaign, an MBA from Northwestern University and a B.A. in chemistry from the University of Illinois at Chicago.
“Vantage is highly regarded by our customers, including many high-profile companies in the food, personal care and industrial markets, for our high-quality products and solutions-oriented focus,” Doktycz said. “I’m proud to officially join Vantage as its CEO to continue to advance our commitment to excellence and smart corporate growth.”